PathoGenetix
利用基因序列掃描技術就行復雜樣品細菌快速鑒定,應用在食品安全檢測,工業微生物學,臨床診斷細菌快速鑒定和菌株分型和研究
PathoGenetix, Inc. is a commercial-stage developer of an automated system for rapid bacterial identification from complex samples. PathoGenetix is a venture-backed company that has received more than $50 million in technology development funding from the Department of Homeland Security. The core Genome Sequence Scanning? (GSS?) technology analyzes DNA from an enriched biological sample—without the need for a cultured isolate—and provides results in five hours. GSS has broad applicability in food safety, industrial microbiology, and clinical diagnostics and research. The GSS technology will be available in the RESOLUTION? Microbial Genotyping System in 2014 for use in food safety testing and foodborne illness outbreak investigations.